ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0382

Increased Rates of Obstetric Complications Prior to Systemic Sclerosis Diagnosis

Melody Chung1, Kathleen Kolstad2, Makdine Dontsi3, Poonam Manwani4, Hongyu Zhao5, Debbie Postlethwaite3, Sumana Kesh6, Julia Simard7 and Lorinda Chung8, 1Stanford University, Stanford, CA, 2Division of Immunology & Rheumatology, Stanford University School of Medicine, Palo Alto, CA, 3Division of Research, Kaiser Permanente Northern California, Oakland, CA, 4UCLA-Olive View Rheumatology Fellowship, Los Angeles, CA, 5Department of Internal Medicine, Kaiser Permanente Santa Clara, Santa Clara, CA, 6Kaiser Permanente Santa Clara, Santa Clara, CA, 7Stanford Medicine, Stanford, CA, 8Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, CA

Meeting: ACR Convergence 2020

Keywords: pregnancy, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Vasculopathy and immune dysfunction likely precede the diagnosis of systemic sclerosis (SSc) by years as evidenced by longstanding Raynaud’s phenomenon prior to diagnosis. Poor obstetric outcomes may also reflect underlying vascular and immune system abnormalities in patients who later develop SSc. We investigated whether obstetric complications prior to SSc diagnosis are more common compared to the general obstetric population.

Methods: A retrospective case-control study was conducted among Kaiser Permanente Northern California (KPNC) pregnant women with subsequent SSc diagnosis (2013 ACR-EULAR classification criteria confirmed by chart review) from 2007-2016. Controls from the general obstetric population were matched 10:1 by maternal age and year of delivery. Exposures of interest included hypertensive disorders of pregnancy (including pre-eclampsia, eclampsia, and gestational hypertension), premature rupture of membranes (PROM), intrauterine growth restriction (IUGR), maternal infections, neonatal intensive care unit (NICU) admission, and preterm birth. Fischer’s exact tests were used to compare categorical variables. Conditional logistic regression models estimated the odds ratio (OR) and corresponding 95% confidence intervals for the outcome SSc.

Results: Median maternal age at delivery was 34 years (range 23-46 years) for 17 SSc cases and 170 matched controls (Table 1). Median time from delivery to SSc diagnosis was 2 years (range 0.2-7.3 years), with 13/17 developing limited cutaneous disease. Compared to controls, SSc cases were more likely to be Hispanic and Black. Obstetric complications were non-significantly higher in women with an eventual SSc diagnosis compared to controls, including hypertensive disorders (17.7% vs. 9.4%), PROM (11.8% vs. 4.1%), IUGR (5.9% vs 1.8%), maternal infection (29.4% vs. 14.1%), NICU admissions (23.5% vs. 7.7%), and preterm birth (29.4% vs. 21.8%). Women with a subsequent diagnosis of SSc were found to have twice the odds of having hypertensive disorders of pregnancy compared with controls, but the results were not statistically significant). Cases had a significantly higher odds of delivering infants requiring NICU admission (Table 2).

Conclusion: Women who eventually develop SSc appeared to have more pregnancy complications, particularly NICU admissions, before overt diagnosis. Larger studies are needed to validate these findings.

Table 1: Baseline characteristics of cases and controls.

Table 2: Conditional logistic regression analysis comparing SSc cases with controls matched on maternal age and year of delivery.


Disclosure: M. Chung, None; K. Kolstad, None; M. Dontsi, None; P. Manwani, None; H. Zhao, None; D. Postlethwaite, None; S. Kesh, None; J. Simard, None; L. Chung, Eicos, 1, Reata, 1, Boehringer Ingelheim, 1, 2, Mitsubishi Tanabe, 1.

To cite this abstract in AMA style:

Chung M, Kolstad K, Dontsi M, Manwani P, Zhao H, Postlethwaite D, Kesh S, Simard J, Chung L. Increased Rates of Obstetric Complications Prior to Systemic Sclerosis Diagnosis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/increased-rates-of-obstetric-complications-prior-to-systemic-sclerosis-diagnosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-rates-of-obstetric-complications-prior-to-systemic-sclerosis-diagnosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology